MAPT-IT1: A Drug Target / Disease Biomarker (G100130148)

Target Name: MAPT-IT1

NCBI ID: G100130148

MAPT-IT1

Other Name(s): MAPT intronic transcript 1

MAPT-IT1: A Drug Target / Disease Biomarker

MAPT-IT1 is a protein that is expressed in various tissues of the body, including the brain, heart, kidneys, and liver. It is a member of the T-cell receptor (TCR) family, which is a protein that is involved in the immune response.

MAPT-IT1 has been identified as a potential drug target because it is involved in several important cellular processes that are crucial for the development and progression of many diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the most significant functions of MAPT-IT1 is its role in the development of cancer.MAPT-IT1 has been shown to promote the growth and survival of cancer cells, and it has been used in several studies as a potential therapeutic target for cancer.

In addition to its role in cancer, MAPT-IT1 is also involved in the development and progression of neurodegenerative diseases, such as Alzheimer's and Parkinson's diseases. These conditions are characterized by the progressive loss of brain cells, and they can have a significant impact on an individual's quality of life.

MAPT-IT1 has been shown to contribute to the development and progression of neurodegenerative diseases by promoting the production of pro-inflammatory cytokines, which can cause damage to the brain cells.

Furthermore, MAPT-IT1 is also involved in the development and progression of autoimmune disorders, such as rheumatoid arthritis and multiple sclerosis. These conditions involve the immune system attacking the body's own tissues, and they can cause significant pain and discomfort.

In addition to its role in disease, MAPT-IT1 has also been shown to have potential therapeutic applications in the treatment of autoimmune disorders. For example, studies have shown that MAPT-IT1 can be used to treat rheumatoid arthritis by suppressing the immune system and reducing inflammation.

Overall, MAPT-IT1 is a protein that has the potential to be a drug target for a variety of diseases. Its role in the development and progression of cancer, neurodegenerative diseases, and autoimmune disorders makes it an attractive target for therapeutic intervention. Further research is needed to fully understand the functions of MAPT-IT1 and its potential as a therapeutic target.

Protein Name: MAPT Intronic Transcript 1

The "MAPT-IT1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MAPT-IT1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets